Keywords: meningitis, cases, vioxx, reported, aim, journal, bextra

Meningitis cases with Vioxx reported in AIM journal; Bextra comparative trial

Article | 01 April 2002

Print This

Merck & Co's COX-2 inhibitor Vioxx (rofecoxib) has been associated with12 cases of nonbacterial meningitis since it become available in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in